NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
0.8184
+0.0072 (0.89%)
Mar 17, 2026, 4:00 PM EDT - Market closed
NeuroSense Therapeutics Market Cap
NeuroSense Therapeutics has a market cap or net worth of $27.33 million as of March 17, 2026. Its market cap has increased by 6.24% in one year.
Market Cap
27.33M
Enterprise Value
26.43M
1-Year Change
6.24%
Ranking
Category
Stock Price
$0.82
Market Cap Chart
Since the IPO on December 9, 2021, NeuroSense Therapeutics's market cap has decreased from $64.61M to $27.33M, a decrease of -57.70%. That is a compound annual growth rate of -18.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 16, 2026 | 27.09M | 18.62% |
| Dec 31, 2025 | 22.84M | -17.70% |
| Dec 31, 2024 | 27.75M | 158.68% |
| Dec 29, 2023 | 10.73M | -24.68% |
| Dec 30, 2022 | 14.24M | -46.24% |
| Dec 31, 2021 | 26.49M | -59.00% |
| Dec 9, 2021 | 64.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Outlook Therapeutics | 29.23M |
| Exicure | 29.21M |
| Xilio Therapeutics | 28.73M |
| Kyntra Bio | 28.33M |
| Barinthus Biotherapeutics | 27.78M |
| Lantern Pharma | 26.95M |
| IGC Pharma | 25.98M |
| Senti Biosciences | 25.80M |